HKU Scholars Hub: Browsing DSpace

Browsing by Author Kindler, HL

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 6 of 6

	Title	Author(s)	Issue Date
	A phase II study of sorafenib in malignant mesothelioma: Results of Cancer and Leukemia Group B 30307 Journal:Journal of Thoracic Oncology	Dubey, S Jänne, PA Krug, L Pang, H Wang, X Heinze, R Watt, C Crawford, J Kratzke, R Vokes, E Kindler, HL	2010
	CALGB 30601: A phase II study of dasatinib (D) in patients (pts) with previously treated malignant mesothelioma (MM) Proceeding/Conference:Journal of Clinical Oncology	Dudek, A Pang, HMH Kratzke, RA Otterson, GA Vokes, EE Kindler, HL	2010
	Coagulation factors in citrated plasma predict for benefit from bevacizumab (B) in patients with advanced pancreatic cancer (APC): Results from CALGB 80303 (Alliance) Proceeding/Conference:Journal of Clinical Oncology	Clarke, JM Pang, HMH Starr, MD Hatch, AJ Kindler, HL O'Reilly, EM Innocenti, F Venook, AP Hurwitz, H Nixon, AB	2015
	Phase II study of dasatinib in patients with previously treated malignant mesothelioma (Cancer and leukemia group B 30601): A brief report Journal:Journal of Thoracic Oncology	Dudek, AZ Pang, H Kratzke, RA Otterson, GA Hodgson, L Vokes, EE Kindler, HL	2012
	Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: Results from CALGB 80303 Proceeding/Conference:Journal of Clinical Oncology	Nixon, AB Pang, HMH Starr, M Hollis, D Friedman, PN Bertagnolli, MM Kindler, HL Goldberg, RM Venook, AP Hurwitz, H	2011
	Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance) Journal:Clinical Cancer Research	Nixon, AB Nixon, AB Nixon, AB Pang, HMH Starr, MD Friedman, PN Bertagnolli, MM Kindler, HL Goldberg, RM Venook, AP Hurwitz, HI	2013

Showing results 1 to 6 of 6